James Noble, Director at Adaptimmune Therapeutics PLC (ADAP), sold 300,000 shares at $4.00 ($1.4M) on 2020-01-13, disclosed to the SEC on 2020-01-15.
Open-market sale of $1.4M ADAP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.00 | 100,000 | $400K | 28.6% |
| 2 | $5.00 | 200,000 | $1.0M | 71.4% |
| Total | $4.67 avg | 300,000 | $1.4M | 100% |
| Filing → |
| CRGN | BUY | 2007-05-09 | $57K | — | Filing → |